| Ident. | Authors (with country if any) | Title |
|---|
| 000106 |
Michael S. Okun [États-Unis] | Parkinson's Disease Patients Cannot Get Their Dopamine Replacement: The 8-Sinemet Limit |
| 000144 |
J. Paul Bolam [Royaume-Uni] ; Eleftheria K. Pissadaki [Royaume-Uni, Grèce] | Living on the Edge With Too Many Mouths to Feed: Why Dopamine Neurons Die |
| 000212 |
Laura D. Perju-Dumbrava [Autriche] ; Gabor G. Kovacs [Autriche] ; Susanne Pirker [Autriche] ; Kurt Jellinger [Autriche] ; Martha Hoffmann [Autriche] ; Susanne Asenbaum [Autriche] ; Walter Pirker [Autriche] | Dopamine Transporter Imaging in Autopsy-Confirmed Parkinson's Disease and Multiple System Atrophy |
| 000213 |
Bernard Ravina [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Roger Kurlan [États-Unis] ; Alberto Ascherio [États-Unis] ; Flint Beal [États-Unis] ; James Beck [États-Unis] ; Emily Flagg [États-Unis] ; Wendy R. Galpern [États-Unis] ; Jennifer Harman [États-Unis] ; Anthony E. Lang [Canada] ; Michael Schwarzschild [États-Unis] ; Caroline Tanner [États-Unis] ; Ira Shoulson [États-Unis] | Dopamine Transporter Imaging Is Associated With Long-Term Outcomes in Parkinson's Disease |
| 000282 |
Sergio E. Starkstein [Australie] | Apathy in Parkinson's Disease: Diagnostic and Etiological Dilemmas |
| 000300 |
Fabrizio Stocchi [Italie] ; Rupam Borgohain [Inde] ; Marco Onofrj [Italie] ; Anthony H. V. Schapira [Royaume-Uni] ; Mohit Bhatt [Inde] ; Valentina Lucini [Italie] ; Rodolfo Giuliani [Italie] ; Ravi Anand [Suisse] | A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients |
| 000318 |
Gerald Stern [Royaume-Uni] | Why Catechol? |
| 000354 |
Ashley H. Spencer [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] ; Alfonso Fasano [Italie] ; Andrea E. Cavanna [Royaume-Uni] | The Prevalence and Clinical Characteristics of Punding in Parkinson's Disease |
| 000403 |
Michael A. Schwarzschild [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Danna Jennings [États-Unis] ; John Seibyl [États-Unis] ; Alberto Ascherio [États-Unis] | Serum Urate and Probability of Dopaminergic Deficit in Early "Parkinson's Disease" |
| 000412 |
Kelvin L. Chou [États-Unis] ; Robert A. Koeppe [États-Unis] ; Nicolaas I. Bohnen [États-Unis] | Rhinorrhea: A Common Nondopaminergic Feature of Parkinson's Disease |
| 000413 |
Dimitrios Kapogiannis [États-Unis] ; Eric Mooshagian [États-Unis] ; Paul Campion [États-Unis] ; Jordan Grafman [États-Unis] ; Trelawny J. Zimmermann [États-Unis] ; Kelsey C. Ladt [États-Unis] ; Eric M. Wassermann [États-Unis] | Reward Processing Abnormalities in Parkinson's Disease |
| 000419 |
Ruth Djaldetti [Israël] ; Mordechai Lorberboym [Israël] ; Yuval Karmon [Israël] ; Therese A. Treves [Israël] ; Ilan Ziv [Israël] ; Eldad Melamed [Israël] | Residual Striatal Dopaminergic Nerve Terminals in Very Long-Standing Parkinson's Disease: A Single Photon Emission Computed Tomography Imaging Study |
| 000503 |
Davide Chiasserini [Italie] ; Alessandro Tozzi [Italie] ; Antonio De Lure [Italie] ; Michela Tantucci [Italie] ; Federica Susta [Italie] ; Pier Luigi Orvietani [Italie] ; Keizo Koya [États-Unis] ; Luciano Binaglia [Italie] ; Paolo Calabresi [Italie] | Mortalin Inhibition in Experimental Parkinson's Disease |
| 000514 |
A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis] | Milestones in Neuroimaging |
| 000579 |
Valerio Pisani [Italie] ; Graziella Madeo [Italie] ; Annalisa Tassone [Italie] ; Giuseppe Sciamanna [Italie] ; Mauro Maccarrone [Italie] ; Paolo Stanzione [Italie] ; Antonio Pisani [Italie] | Homeostatic Changes of the Endocannabinoid System in Parkinson's Disease |
| 000587 |
Marios Politis [Royaume-Uni] ; Wolfgang H. Oertel [Allemagne] ; KIT WU [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Oliver Pogarell [Allemagne] ; David J. Brooks [Royaume-Uni] ; Anders Bjorklund [Suède] ; Olle Lindvall [Suède] ; Paola Piccini [Royaume-Uni] | Graft-Induced Dyskinesias in Parkinson's Disease: High Striatal Serotonin/Dopamine Transporter Ratio |
| 000632 |
Thomas D. H Lbig [États-Unis, Allemagne] ; Stephanie Assuras [États-Unis] ; Judy Creighton [États-Unis] ; Joan C. Borod [États-Unis] ; Winona Tse [États-Unis] ; Pasquale G. Frisina [États-Unis] ; Andrei Voustianiouk [États-Unis] ; Jean-Michel Gracies [États-Unis] ; C. Warren Olanow [États-Unis] | Differential Role of Dopamine in Emotional Attention and Memory: Evidence from Parkinson's Disease |
| 000644 |
Morvarid Karimi [États-Unis] ; Stephen M. Moerlein [États-Unis] ; Tom O. Videen [États-Unis] ; Robert R. Luedtke [États-Unis] ; Michelle Taylor [États-Unis] ; Robert H. Mach [États-Unis] ; Joel S. Perlmutter [États-Unis] | Decreased Striatal Dopamine Receptor Binding in Primary Focal Dystonia: A D2 or D3 Defect? |
| 000681 |
Nin P. S. Bajaj [Royaume-Uni] ; Maria Knöbel [Royaume-Uni] ; Vamsi Gontu [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Can Spiral Analysis Predict the FP-CIT SPECT Scan Result in Tremulous Patients? |
| 000709 |
Danielle M. Shore [Royaume-Uni] ; Robert Rafal [Royaume-Uni] ; John A. Parkinson [Royaume-Uni] | Appetitive Motivational Deficits in Individuals with Parkinson's Disease |
| 000730 |
Catherine L. Gallagher [États-Unis] ; Bradley T. Christian [États-Unis] ; James E. Holden [États-Unis] ; Onofre T. Dejesus [États-Unis] ; Robert J. Nickles [États-Unis] ; Laura Buyan-Dent [États-Unis] ; Barbara B. Bendlin [États-Unis] ; Sandra J. Harding [États-Unis] ; Charles K. Stone [États-Unis] ; Barb Mueller [États-Unis] ; Sterling C. Johnson [États-Unis] | A Within-Subject Comparison of 6-[18F]Fluoro-m-tyrosine and 6-[18F]Fluoro-L-dopa in Parkinson's Disease |
| 000A40 |
Ryuji Sakakibara [Japon] ; Tomoyuki Uchiyama [Japon] ; Tomonori Yamanishi [Japon] ; Masahiko Kishi [Japon] | Genitourinary Dysfunction in Parkinson's Disease |
| 000A42 |
Tomas Bjorklund [Suède] ; Jeffrey H. Kordower [États-Unis] | Gene Therapy for Parkinson's Disease |
| 000A81 |
Giselle M. Petzinger [États-Unis] ; Beth E. Fisher [États-Unis] ; Jon-Eric Van Leeuwen [États-Unis] ; Marta Vukovic [États-Unis] ; Gamik Akopian [États-Unis] ; Charlie K. Meshul [États-Unis] ; Daniel P. Holschneider [États-Unis] ; Angelo Nacca [États-Unis] ; John P. Walsh [États-Unis] ; Michael W. Jakowec [États-Unis] | Enhancing Neuroplasticity in the Basal Ganglia: The Role of Exercise in Parkinson's Disease |
| 000B00 |
Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Ramachandiran Nandhagopal [Canada] ; Michael Schulzer [Canada] ; Jessamyn Mckenzie [Canada] ; Thomas J. Ruth [Canada] ; Jan O. Aasly [Norvège] ; Matthew J. Farrer [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Jon A. Stoessl [Canada] | Dopamine Turnover Increases in Asymptomatic LRRK2 Mutations Carriers |
| 000B01 |
Leena Subramanian [Royaume-Uni] ; John Vincent Hindle [Royaume-Uni] ; Margaret Cecilia Jackson [Royaume-Uni] ; David E. J. Linden [Royaume-Uni] | Dopamine Boosts Memory for Angry Faces in Parkinson's Disease |
| 000B28 |
Sophie Bayard [France] ; HUAN YU [France, République populaire de Chine] ; Muriel Croisier Lanpenier [France] ; Bertrand Carlander [France] ; Yves Dauvilliers [France] | Decision Making in Restless Legs Syndrome |
| 000B97 |
Petra Schwingenschuh [Royaume-Uni, Autriche] ; Petra Katschnig [Royaume-Uni, Autriche] ; Ronald Saurugg [Autriche] ; Erwin Ott [Autriche] ; Kailash P. Bhatia [Royaume-Uni] | Artistic Profession: A Potential Risk Factor for Dopamine Dysregulation Syndrome in Parkinson's Disease? |
| 000C38 |
C. Savio Chan [États-Unis] ; Tracy S. Gertler [États-Unis] ; D. James Surmeier [États-Unis] | A Molecular Basis for the Increased Vulnerability of Substantia Nigra Dopamine Neurons in Aging and Parkinson's Disease |
| 000C61 |
Christopher M. Knapp [Royaume-Uni] ; Irene Gottlob [Royaume-Uni] ; Rebecca J. Mclean [Royaume-Uni] ; Yusuf A. Rajabally [Royaume-Uni] ; Richard J. Abbott [Royaume-Uni] ; Suzanne Rafelt [Royaume-Uni] ; Frank A. Proudlock [Royaume-Uni] | Vertical Optokinetic Nystagmus in Parkinson's Disease |
| 000C64 |
Daniel Weintraub [États-Unis] ; Staci Hoops [États-Unis] ; Judy A. Shea [États-Unis] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Erika D. Driver-Dunckley [États-Unis] ; Charles H. Adler [États-Unis] ; Marc N. Potenza [États-Unis] ; Janis Miyasaki [Canada] ; Andrew D. Siderowf [États-Unis] ; John E. Duda [États-Unis] ; Howard I. Hurtig [États-Unis] ; Amy Colcher [États-Unis] ; Stacy S. Horn [États-Unis] ; Matthew B. Stern [États-Unis] ; Valerie Voon [États-Unis] | Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease |
| 000D03 |
Francesco Roselli [Italie, Allemagne] ; Nicola M. Pisciotta [Italie] ; Robert Pemeczky [Allemagne] ; Michele Pennelli [Italie] ; Maria S. Aniello [Italie] ; Maria F. De Caro [Italie] ; Ermanno Ferrannini [Italie] ; Bruno Tartaglione [Italie] ; Giovanni Defazio [Italie] ; Giuseppe Rubini [Italie] ; Paolo Livrea [Italie] | Severity of Neuropsychiatric Symptoms and Dopamine Transporter Levels in Dementia with Lewy Bodies: A 123I-FP-CIT SPECT Study |
| 000D06 |
Nadeeka N. W. Dissanayaka [Australie] ; Peter A. Silburn [Australie] ; John D. O'Sullivan [Australie] ; George D. Mellick [Australie] | Serotonin and Dopamine Transporter Genes Do Not Influence Depression in Parkinson's Disease |
| 000E39 |
Andrew H. Evans [Australie] ; Antonio P. Strafella [Canada] ; Daniel Weintraub [États-Unis] ; Mark Stacy [États-Unis] | Impulsive and Compulsive Behaviors in Parkinson's Disease |
| 000E78 |
Ji E. Lee [Corée du Sud] ; Hae-Won Shin [Corée du Sud] ; Kyung S. Kim [Corée du Sud] ; Young H. Sohn [Corée du Sud] | Factors Contributing to the Development of Restless Legs Syndrome in Patients with Parkinson Disease |
| 000F05 |
Rodney W. H. Walker [Royaume-Uni] ; Zuzana Walker [Royaume-Uni] | Dopamine Transporter Single Photon Emission Computerized Tomography in the Diagnosis of Dementia with Lewy Bodies |
| 000F06 |
Christoph Scherfler [Autriche] ; Michael Nocker [Autriche] | Dopamine Transporter SPECT: How to Remove Subjectivity? |
| 000F40 |
Gabriel Robert [France] ; Dominique Drapier [France] ; Marc Verin [France] ; Bruno Millet [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] | Cognitive Impulsivity in Parkinson's Disease Patients: Assessment and Pathophysiology |
| 001018 |
Michele Tinazzi [Italie] ; Sarah Ottaviani [Italie] ; Ioannis U. Isaias [Italie] ; Isabella Pasquin [Italie] ; Maria Steinmayr [Italie] ; Claudio Vampini [Italie] ; Manuela Pilleri [Italie] ; Giuseppe Moretto [Italie] ; Antonio Fiaschi [Italie] ; Nicola Smania [Italie] ; Piergiorgio Giorgetti [Italie] ; Angelo Antonini [Italie] | [123I]FP-CIT SPET Imaging in Drug-Induced Parkinsonism |
| 001059 |
Stanley Fahn [États-Unis] | The History of Dopamine and Levodopa in the Treatment of Parkinson's Disease |
| 001087 |
Yoland Smith [États-Unis] ; Rosa Villalba [États-Unis] | Striatal and Extrastriatal Dopamine in the Basal Ganglia : An Overview of its Anatomical Organization in Normal and Parkinsonian Brains |
| 001088 |
Irena Rektorova [République tchèque] ; Hana Srovnalova [République tchèque] ; Radka Kubikova [République tchèque] ; Jiri Prasek [République tchèque] | Striatal Dopamine Transporter Imaging Correlates with Depressive Symptoms and Tower of London Task Performance in Parkinson's Disease |
| 001131 |
Roberto Ceravolo [Italie] ; Angelo Antonini [Italie] ; Duccio Volterrani [Italie] ; Carlo Rossi [Italie] ; Lorenzo Kiferle [Italie] ; Daniela Frosini [Italie] ; Claudio Lucetti [Italie] ; Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Luigi Murri [Italie] ; Ubaldo Bonuccelli [Italie] | Predictive Value of Nigrostriatal Dysfunction in Isolated Tremor : A Clinical and SPECT Study |
| 001138 |
Anthony A. Grace [États-Unis] | Physiology of the Normal and Dopamine-Depleted Basal Ganglia : Insights into Levodopa Pharmacotherapy |
| 001165 |
Gabor G. Kovacs [Autriche] ; Ivan J. Milenkovic [Autriche] ; Matthias Preusser [Autriche] ; Herbert Budka [Autriche] | Nigral Burden of α-Synuclein Correlates with Striatal Dopamine Deficit |
| 001207 |
C. Warren Olanow [États-Unis] | Levodopa/Dopamine Replacement Strategies in Parkinson's Disease-Future Directions |
| 001210 |
Mercedes Serrano [Espagne] ; Belen Perez-Duenas [Espagne] ; Aida Ormazabal [Espagne] ; Rafael Artuch [Espagne] ; Jaume Campistol [Espagne] ; Rosa J. Torres [Espagne] ; Angels Garcia-Cazorla [Espagne] | Levodopa Therapy in a Lesch-Nyhan Disease Patient : Pathological, Biochemical, Neuroimaging, and Therapeutic Remarks |
| 001242 |
Evelien Huisman [Pays-Bas] ; Harry B. M. Uylings [Pays-Bas] ; Piet V. Hoogland [Pays-Bas, Afrique du Sud] | Gender-Related Changes in Increase of Dopaminergic Neurons in the Olfactory Bulb of Parkinson's Disease Patients |
| 001259 |
Karen E. Murphy [Australie] ; Tanya Karaconji [Australie] ; Craig D. Hardman [Australie] ; Glenda M. Halliday [Australie] | Excessive Dopamine Neuron Loss in Progressive Supranuclear Palsy |
| 001366 |
Virginie Czernecki [France] ; Michael Schüpbach [France, Suisse] ; Sadek Yaici [France] ; Richard Levy [France] ; Eric Bardinet [France] ; Jérome Yelnik [France] ; Bruno Dubois [France] ; Yves Agid [France] | Apathy Following Subthalamic Stimulation in Parkinson Disease : A Dopamine Responsive Symptom |
| 001413 |
Walter Paulus [Allemagne] ; Pascal Dowling [Allemagne] ; Roselyne Rijsman [Pays-Bas] ; Karin Stiasny-Kolster [Allemagne] ; Claudia Trenkwalder [Allemagne] | Update of the Pathophysiology of the Restless-Legs-Syndrome |
| 001479 |
Christoph Scherfler [Autriche] ; Johannes Schwarz [Allemagne] ; Angelo Antonini [Italie] ; Donald Grosset [Royaume-Uni] ; Francesc Valldeoriola [Espagne] ; Kenneth Marek [États-Unis] ; Wolfgang Oertel [Allemagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] | Role of DAT-SPECT in the diagnostic work up of parkinsonism |
| 001495 |
Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis] | Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (Tesofensine) in early parkinson's disease |
| 001527 |
Andrew J. Lawrence [Royaume-Uni] ; Andrew D. Blackwell [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Francesca Spagnolo [Italie] ; Luke Clark [Royaume-Uni] ; Michael R. F. Aitken [Royaume-Uni] ; Barbara J. Sahakian [Royaume-Uni] | Predictors of Punding in Parkinson's Disease : Results from a Questionnaire Survey |
| 001543 |
Walter Paulus [Allemagne] ; Pascal Dowling [Allemagne] ; Roselyne Rijsman [Pays-Bas] ; Karin Stiasny-Kolster [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Al De Weerd [Pays-Bas] | Pathophysiological concepts of restless legs syndrome |
| 001545 |
David A. Gallagher [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Andrew H. Evans [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Anette Schrag [Royaume-Uni] | Pathological gambling in parkinson's disease : Risk factors and differences from dopamine dysregulation. An analysis of published case series |
| 001569 |
Katie Kompoliti [États-Unis] ; YAPING CHU [États-Unis] ; Kathleen M. Shannon [États-Unis] ; Jeffrey H. Kordower [États-Unis] | Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient |
| 001648 |
Ming Chi Shih [Brésil] ; Luiz Augusto Franco De Andrade [Brésil] ; Edson Jr Amaro [Brésil] ; Andre Carvalho Felicio [Brésil] ; Henrique Ballalai Ferraz [Brésil] ; Jairo Wagner [Brésil] ; Marcelo Queiroz Hoexter [Brésil] ; LI FU LIN [Taïwan] ; YING KAI FU [Taïwan] ; Jair Jesus Mari [Brésil] ; Sergio Tufik [Brésil] ; Rodrigo Affonseca Bressan [Brésil] | Higher nigrostriatal dopamine neuron loss in early than late onset Parkinson's disease?-A [99mTc]-TRODAT-1 SPECT study |
| 001705 |
Eman M. Khedr [Égypte] ; John C. Rothwell [Royaume-Uni] ; Ola A. Shawky [Égypte] ; Mohammed A. Ahmed [Égypte] ; Nageh Foly [Égypte] ; Ahmed Hamdy [Égypte] | Dopamine levels after repetitive transcranial magnetic stimulation of motor cortex in patients with Parkinson's disease: Preliminary results |
| 001733 |
Russell C. Dale [Australie] ; Richard Webster [Australie] ; Deepak Gill [Australie] | Contemporary Encephalitis Lethargica Presenting with Agitated Catatonia, Stereotypy, and Dystonia-Parkinsonism |
| 001806 |
Jaime Kulisevsky [Espagne] ; Berta Pascual-Sedano [Espagne] ; Manel Barbanoj [Espagne] ; Alexandre Gironell [Espagne] ; Javier Pagonabarraga [Espagne] ; Carmen Garcia-Sanchez [Espagne] | Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease : A double-blind study |
| 001881 |
Vicky L. Marshall [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Successful antiparkinsonian medication withdrawal in patients with parkinsonism and normal FP-CIT SPECT |
| 001891 |
Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Stefano Goldwurm [Italie] ; Michela Zini [Italie] ; Roberto Cilia [Italie] ; Paolo Gerundini [Italie] ; Alessio Di Fonzo [Pays-Bas, Italie] ; Vincenzo Bonifati [Pays-Bas, Italie] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] | Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation |
| 001933 |
Laura Silveira-Moriyama [Royaume-Uni] ; Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Punding and dyskinesias |
| 001950 |
Maurizio Avanzi [Italie] ; Mario Baratti [Italie] ; Silvia Cabrini [Italie] ; Elena Uber [Italie] ; Gianni Brighetti [Italie] ; Flavio Bonfa [Italie] | Prevalence of pathological gambling in patients with Parkinson's disease |
| 001972 |
Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommee [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France] | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
| 001985 |
Plamen Gatev [États-Unis] ; Olivier Darbin [États-Unis] ; Thomas Wichmann [États-Unis] | Oscillations in the basal ganglia under normal conditions and in movement disorders |
| 001987 |
Kaveh M. Koochesfahani [Canada] ; Raul De La Fuente-Fernandez [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada] | Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients : Positron emission tomographic studies |
| 001A81 |
William Bara-Jimenez [États-Unis] ; Tzvetelina D. Dimitrova [États-Unis] ; Abdullah Sherzai [États-Unis] ; Murat Aksu [États-Unis] ; Thomas N. Chase [États-Unis] | Glutamate release inhibition ineffective in levodopa-induced motor complications |
| 001A84 |
Katie Kompoliti [États-Unis] ; Christopher G. Goetz [États-Unis] ; Mary Morrissey [États-Unis] ; Sue Leurgans [États-Unis] | Gilles de la tourette syndrome : Patient's knowledge and concern of adverse effects |
| 001D04 |
Antonio Pisani [Italie] ; Diego Centonze [Italie] ; Giorgio Bemardi [Italie] ; Paolo Calabresi [Italie] | Striatal synaptic plasticity : Implications for motor learning and Parkinson's disease |
| 001D45 |
Francesca Romana Pezzella [Italie] ; Carlo Colosimo [Italie] ; Nicola Vanacore [Italie] ; Simone Di Rezze [Italie] ; Melania Chianese [Italie] ; Giovanni Fabbrini [Italie] ; Giuseppe Meco [Italie] | Prevalence and clinical features of Hedonistic homeostatic dysregulation in Parkinson's disease |
| 001E08 |
Jan Lewerenz [Allemagne] ; Bartosz Zurowski [Allemagne] ; Lars Jenicke [Allemagne] ; Tobias B Umer [Allemagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Alexander Miinchau [Allemagne] | Lesion of the dorsorostral midbrain sparing the nigrostriatal tract mimics axial rigidity seen in progressive supranuclear palsy |
| 001E52 |
Jörg Spiegel [Allemagne] ; Marc-Oliver Mollers [Allemagne] ; Wolfgang H. Jost [Allemagne] ; Gerhard Fuss [Allemagne] ; Ulrich Dillmann [Allemagne] ; Georg Becker [Allemagne] ; Carl-Martin Kirsch [Allemagne] | FP-CIT and MIBG scintigraphy in early Parkinson's disease |
| 001E63 |
William Bara-Jimenez [États-Unis] ; Francesco Bibbiani [États-Unis] ; Michael J. Morris [États-Unis] ; Tzvetelina Dimitrova [États-Unis] ; Abdullah Sherzai [États-Unis] ; Maral M. Mouradian [États-Unis] ; Thomas N. Chase [États-Unis] | Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease |
| 001E74 |
Michelle Porritt [Australie] ; Davor Stanic [Australie] ; David Finkelstein [Australie] ; Peter Batchelor [Australie] ; Sharon Lockhart [Australie] ; Andrew Hughes [Australie] ; Renate Kalnins [Australie] ; David Howells [Australie] | Dopaminergic innervation of the human striatum in Parkinson's disease |
| 001E75 |
Hae-Won Shin [Corée du Sud] ; Suk Y. Kang [Corée du Sud] ; Young H. Sohn [Corée du Sud] | Dopaminergic influence on disturbed spatial discrimination in Parkinson's disease |
| 001F45 |
Tatiana Witjas [France] ; Christelle Baunez [France] ; Jean Marc Henry [France] ; Marie Delfini [France] ; Jean Regis [France] ; André Ali Cherif [France] ; Jean Claude Peragut [France] ; Jean Philippe Azulay [France] | Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation |
| 002034 |
Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; Dominic Paviour [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Silke Appel [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome |
| 002135 |
Ana M. Catafau [Espagne] ; Eduardo Tolosa [Espagne] | Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes |
| 002215 |
J. Eric Ahlskog [États-Unis] | Challenging conventional wisdom : The etiologic role of dopamine oxidative stress in Parkinson's disease |
| 002234 |
Marlene Jimenez Del Rio [Colombie] ; Sonia Moreno [Colombie] ; Gloria Garcia-Ospina [Colombie] ; Omar Buritica [Colombie] ; Carlos S. Uribe [Colombie] ; Francisco Lopera [Colombie] ; Carlos Velez-Pardo [Colombie] | Autosomal recessive juvenile parkinsonism Cys212Tyr mutation in arkin renders lymphocytes susceptible to dopamine- and iron-mediated apoptosis |
| 002257 |
Susan Hollan [Hongrie] ; Laszlo Vecsei [Hongrie] ; D. Kalman Magyar [Hongrie] | Adverse effects of dopamine potentiation by long-term treatment with selegiline |
| 002272 |
| Dopamine transporter imaging |
| 002292 |
Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France] | Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue |
| 002331 |
Vicky Marshall [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders |
| 002332 |
Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Role of dopamine transporter imaging in routine clinical practice |
| 002333 |
Werner Poewe [Autriche] ; Christoph Scherfler [Autriche] | Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice |
| 002334 |
Wolfgang H. Oertel [Allemagne] ; Anja Gerstner [Allemagne] ; Helmut Höffken [Allemagne] ; Richard C. Dodel [Allemagne] ; Karla M. Eggert [Allemagne] ; Jens C. Möller [Allemagne] | Role of dopamine transporter SPECT for the practitioner and the general neurologist |
| 002422 |
David R. Lynch [États-Unis] ; P. David Mozley [États-Unis] ; Set Sokol [États-Unis] ; Nicole M. C. Maas [États-Unis] ; Laura J. Balcer [États-Unis] ; Andrew D. Siderowf [États-Unis] | Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease |
| 002436 |
Paul K. Morrish [Royaume-Uni] | How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease? |
| 002470 |
Manuel Rodriguez Diaz [Espagne] ; Pedro Barroso-Chinea [Espagne] ; Abraham Acevedo [Espagne] ; Tomas Gonzalez-Hernandez [Espagne] | Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: Different action on GABA cell subpopulations |
| 002480 |
George R. Uhl [États-Unis] | Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism |
| 002481 |
Paola P. Piccini [Royaume-Uni] | Dopamine transporter: Basic aspects and neuroimaging |
| 002482 |
Richard C. Dodel [Allemagne] ; Helmut Höffken [Allemagne] ; J. Carsten Möller [Allemagne] ; Bernhard Bornschein [Allemagne] ; Thomas Klockgether [Allemagne] ; Thomas Behr [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Uwe Siebert [États-Unis, Allemagne] | Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: A decision-analytic approach |
| 002493 |
Durval C. Costa [Royaume-Uni, Portugal] ; Zuzana Walker [Royaume-Uni] ; Rodney W. H. Walker [Royaume-Uni] ; Flavia R. G. Fontes [Royaume-Uni] | Dementia with Lewy bodies versus alzheimer's disease: Role of dopamine transporter imaging |
| 002497 |
Ruediger Hilker [Allemagne] ; Juergen Voges [Allemagne] ; Mehran Ghaemi [Allemagne] ; Ralf Lehrke [Allemagne] ; Jobst Rudolf [Allemagne] ; Athanasios Koulousakis [Allemagne] ; Karl Herholz [Allemagne] ; Klaus Wienhard [Allemagne] ; Volker Sturm [Allemagne] ; Wolf-Dieter Heiss [Allemagne] | Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in Parkinsonian humans |
| 002499 |
Joong-Seok Kim [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud] ; Si-Ryung Han [Corée du Sud] ; Yong-An Chung [Corée du Sud] | Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis |
| 002500 |
Eduardo Tolosa [Espagne] ; Miguel Coelho [Espagne] ; Marisol Gallardo [Espagne] | DAT imaging in drug-induced and psychogenic parkinsonism |
| 002504 |
Walter Pirker [Autriche] | Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it? |
| 002519 |
Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications |
| 002558 |
Willibald Gerschlager [Autriche, Royaume-Uni] ; Gerhard Bencsits [Autriche] ; Walter Pirker [Autriche] ; Bastiaan R. Bloem [Royaume-Uni, Pays-Bas] ; Susanne Asenbaum [Autriche] ; Daniella Prayer [Autriche] ; Jan C. M. Zijlmans [Royaume-Uni] ; Martha Hoffmann [Autriche] ; Thomas Brücke [Autriche] | [123I]β-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease |
| 002582 |
Ronald K. B. Pearce [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jorgen Scheel-Krüger [Danemark] ; Peter Jenner [Royaume-Uni] | The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets |
| 002791 |
Y. Kim [Corée du Sud] ; J.-M. Kim [Corée du Sud] ; J.-W. Kim [Corée du Sud] ; C.-I. Yoo [Corée du Sud] ; C. R. Lee [Corée du Sud] ; J. H. Lee [Corée du Sud] ; H. K. Kim [Corée du Sud] ; S. O. Yang [Corée du Sud] ; H. K. Chung [Corée du Sud] ; D. S. Lee [Corée du Sud] ; B. Jeon [Corée du Sud] | Dopamine transporter density is decreased in parkinsonian patients with a history of Manganese exposure: What does it mean? |
| 002792 |
Oleh Hornykiewicz [Autriche] | Dopamine miracle: From brain homogenate to dopamine replacement |
| 002836 |
John L. Goudreau [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Andrew B. Singleton [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis] | Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease |
| 002872 |
Andrea Varrone [États-Unis] ; Kenneth L. Marek [États-Unis] ; Danna Jennings [États-Unis] ; Robert B. Innis [États-Unis] ; John P. Seibyl [États-Unis] | [123I]β-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's Disease and multiple system atrophy |
| 002873 |
Tarja H. Haapaniemi [Finlande] ; Aapo Ahonen [Finlande] ; Pentti Tomiainen [Finlande] ; Kyosti A. Sotaniemi [Finlande] ; Vilho V. Myllyl [Finlande] | [123I]β-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients |
| 002898 |
Arthur Korten [Pays-Bas] ; Jan Lodder [Pays-Bas] ; Fred Vreeling [Pays-Bas] ; Anita Boreas [Pays-Bas] ; Lisette Van Raak [Pays-Bas] ; Fons Kessels [Pays-Bas] | Stroke and idiopathic Parkinson's disease : Does a shortage of dopamine offer protection against stroke? |
| 002990 |
Susanne Goldstein [États-Unis] ; Joseph H. Friedman [États-Unis] ; Robert Innis [États-Unis] ; John Seibyl [États-Unis] ; Kenneth Marek [États-Unis] | Hemi-parkinsonism due to a midbrain arteriovenous malformation : Dopamine transporter imaging |
| 002A50 |
Christopher J. Earley [États-Unis] ; Keith Hyland [États-Unis] ; Richard P. Allen [États-Unis] | CSF dopamine, serotonin, and biopterin metabolites in patients with Restless Legs Syndrome |
| 002B50 |
P. E. Greene [États-Unis] ; S. B. Bressman [États-Unis] ; B. Ford [États-Unis] ; K. Hyland [États-Unis] | Parkinsonism, dystonia, and hemiatrophy |
| 002C10 |
Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Endogenous dopaminergic tone and dopamine agonist action |
| 002D02 |
A. E. Kingsbury [Royaume-Uni] ; D. Marsden [Royaume-Uni] ; O. J. F. Foster [Royaume-Uni] | The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis : An in situ hybridization study |
| 002D25 |
D. Mathen [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] | SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia |
| 002D68 |
A. Brashear [États-Unis] ; G. K. Mulholland [États-Unis] ; Q.-H. Zheng [États-Unis] ; M. R. Farlow [États-Unis] ; E. R. Siemers [États-Unis] ; G. D. Hutchins [États-Unis] | PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP) |
| 002D69 |
F. Cardozo-Pelaez [États-Unis] ; SHIJIE SONG ; A. Parthasarathy ; C. Hazzi ; K. Naidu ; J. Sanchez-Ramos | Oxidative DNA damage in the aging mouse brain |
| 002D71 |
T. Müller [Allemagne] ; H. Przuntek [Allemagne] ; W. Kuhn [Allemagne] ; S. S. Baum [Allemagne] ; H. Rommelspacher [Allemagne] | No increase of synthesis of (R)salsolinol in Parkinson's disease |
| 002E25 |
R. B. Innis [États-Unis] ; K. L. Marek [États-Unis] ; K. Sheff [États-Unis] ; S. Zoghbi [États-Unis] ; J. Castronuovo [États-Unis] ; A. Feigin [États-Unis] ; J. P. Seibyl [États-Unis] | Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]β-CIT |
| 003106 |
J. Schwarz [Allemagne] ; K. Tatsch [Allemagne] ; T. Gasser ; G. Arnold ; W. H. Oertel | [123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy |
| 003130 |
M. Jaber [États-Unis] ; S. Jones ; B. Giros ; M. G. Caron | The dopamine transporter : A crucial component regulating dopamine transmission |
| 003239 |
J. N. Joyce [États-Unis] ; G. Smutzer [États-Unis] ; C. J. Whitty [États-Unis] ; A. Myers [États-Unis] ; M. J. Bannon [États-Unis] | Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease |
| 003276 |
D. G. Le Couteur [Australie] ; P. W. Leighton [Australie] ; S. J. Mccann [Australie] ; S. M. Pond [Australie] | Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease |
| 003357 |
B. R. Bloem [Pays-Bas] ; D. J. Beckley [États-Unis] ; J. G. Van Dijk [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; M. P. Remler [États-Unis] ; R. A. C. Roos [Pays-Bas] | Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease |
| 003455 |
M. Di Capua [Italie] ; E. Bertini | Remission in dihydroxyphenylalanine-responsive dystonia |
| 003480 |
R. Inzelberg [Israël] ; P. Nisipeanu ; M. J. Rabey ; A. D. Korczyn | Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease |
| 003485 |
J. Opacka-Juffry [Royaume-Uni] ; D. J. Brooks | L-dihydroxyphenylalanine and its decarboxylase : new ideas on their neuroregulatory roles |
| 003539 |
G. K. Wenning [Royaume-Uni] ; M. T. O'Connell ; P. N. Patsalos ; N. P. Quinn | A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease |
| 003540 |
A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France] | A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine |
| 003588 |
G. Pezzoli [Italie] ; E. Martignoni ; C. Pacchetti ; V. A. Angeleri ; P. Lamberti ; A. Muratorio ; U. Bonuccelli ; M. De Mari ; N. Foschi ; E. Cossutta ; F. Nicoletti ; F. Giammona ; M. Cansei [Italie] ; G. Scarlato [Italie] ; T. Caraceni ; E. Moscarelli | Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study |
| 003598 |
L. V. Metman [États-Unis] ; V. H. Sethy ; J. R. Roberts ; D. Bravi ; J. I. Hoff ; M. M. Mouradian ; T. N. Chase | Motor effects of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (Preclamol) in Parkinson's disease |
| 003633 |
S. Rose [Royaume-Uni] ; P. Jenner ; C. D. Marsden | Chronic administration does not alter the accumulation of L-dopa into muscle |
| 003917 |
D. Eidelberg ; J. R. Moeller ; V. Dhawan ; J. J. Sidtis ; J. Z. Ginos ; S. C. Strother ; J. Cedarbaum ; P. Greene ; S. Fahn ; D. A. Rottenberg | The metabolic anatomy of Parkinson's disease : complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies |
| 003947 |
C. G. Goetz ; C. M. Tanner | Gilles de la Tourette's syndrome in twins: clinical and neurochemical data |
| 003A39 |
J. G. De Yebenes ; M. F. Brin ; M. A. Mena ; C. De Felipe ; R. M. Del Rio ; E. Bazan ; A. Martinez ; S. Fahn ; J. Del Rio ; A. Vazquez ; E. Varela De Seijas | Neurochemical findings in neuroacanthocytosis |
| 003A90 |
J. G. De Yebenes ; S. Fahn ; S. Lovelle ; V. Jackson-Lewis ; P. Jorge ; M. A. Mena ; J. Reiriz ; J. C. Bustos ; C. Magarinos ; A. Martinez | Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease |
